Biotech · Private company
Crossignal Therapeutics, Inc.
Track this companyFree. Adds Crossignal Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- CT3001Phase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin)Phase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Study to Determine the Effect of CT3001 in Patients With Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Sep 20, 2024ClinicalTrials.gov NCT06598007 · fetched Nov 12, 2026